ICD-10 Coding for Chemo-Induced Neuropathy(G62.0, T45.1x5-)
Complete ICD-10-CM coding and documentation guide for Chemo-Induced Neuropathy. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Chemo-Induced Neuropathy
G60-G64Primary Range
Polyneuropathies and other disorders of the peripheral nervous system
This range includes codes for various types of neuropathies, including drug-induced polyneuropathy.
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
This range includes codes for adverse effects of drugs, including chemotherapy agents.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G62.0 | Drug-induced polyneuropathy | Use when neuropathy is confirmed to be caused by chemotherapy drugs. |
|
| T45.1x5- | Adverse effect of antineoplastic and immunosuppressive drugs | Use to indicate adverse effects of chemotherapy drugs. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for chemo induced neuropathy
Essential facts and insights about Chemo-Induced Neuropathy
Primary ICD-10-CM Codes for chemo induced neuropathy
Decision Criteria
clinical Criteria
- Neuropathy symptoms onset after chemotherapy initiation
documentation Criteria
- Explicit documentation linking neuropathy to chemotherapy
Applicable To
- Polyneuropathy due to drugs
Clinical Validation Requirements
- EMG/NCS showing reduced sensory amplitude
- Exclusion of other causes like diabetes or B12 deficiency
Code-Specific Risks
- Incorrectly using without T45.1x5- code
- Not documenting the causal relationship
Coding Notes
- Ensure documentation explicitly links neuropathy to chemotherapy.
T45.1x5- - Adverse effect of antineoplastic and immunosuppressive drugs
Use to indicate adverse effects of chemotherapy drugs.
Applicable To
- Adverse effects of chemotherapy drugs
Excludes
- Poisoning by antineoplastic drugs (T45.1x1-)
Clinical Validation Requirements
- Documentation of chemotherapy treatment
- Symptoms consistent with drug adverse effects
Coding Notes
Ensure correct 7th character is applied based on encounter type.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Adverse effect of antineoplastic and immunosuppressive drugs
T45.1x5-Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Diabetic polyneuropathy
E11.42Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Chemo-Induced Neuropathy to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code G62.0.
Impact
Clinical: May lead to incorrect treatment plans., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation Strategy
Ensure specific documentation linking symptoms to chemotherapy., Use structured templates for consistency.
Impact
Reimbursement: May result in denied claims or reduced payment., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate representation of patient's condition.
Mitigation Strategy
Always pair G62.0 with T45.1x5- to indicate the cause.
Impact
Reimbursement: Incorrect character may affect DRG assignment., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Misrepresentation of treatment phase.
Mitigation Strategy
Use 'A' for initial, 'D' for subsequent, and 'S' for sequela encounters.
Impact
Incorrect sequencing of T45.1x5- and G62.0.
Mitigation Strategy
Regular training on ICD-10 guidelines and updates.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Chemo-Induced Neuropathy, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Chemo-Induced Neuropathy
Use these documentation templates to ensure complete and accurate documentation for Chemo-Induced Neuropathy. These templates include all required elements for proper coding and billing.
Oncology Progress Note
Specialty: OncologyRequired Elements
- Subjective: Description of neuropathy onset and symptoms.
- Objective: Sensory testing and reflexes.
- Assessment: Grade of CIPN and exclusion of other causes.
- Plan: Treatment adjustments and follow-up.
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Chemo-Induced Neuropathy? Ask your questions below.